JP2012507997A5 - - Google Patents

Download PDF

Info

Publication number
JP2012507997A5
JP2012507997A5 JP2011535119A JP2011535119A JP2012507997A5 JP 2012507997 A5 JP2012507997 A5 JP 2012507997A5 JP 2011535119 A JP2011535119 A JP 2011535119A JP 2011535119 A JP2011535119 A JP 2011535119A JP 2012507997 A5 JP2012507997 A5 JP 2012507997A5
Authority
JP
Japan
Prior art keywords
cell
derived
component
cells
immunoregulatory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011535119A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012507997A (ja
JP5745419B2 (ja
Filing date
Publication date
Priority claimed from GBGB0820397.8A external-priority patent/GB0820397D0/en
Application filed filed Critical
Publication of JP2012507997A publication Critical patent/JP2012507997A/ja
Publication of JP2012507997A5 publication Critical patent/JP2012507997A5/ja
Application granted granted Critical
Publication of JP5745419B2 publication Critical patent/JP5745419B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011535119A 2008-11-07 2009-11-06 細胞、核酸構築物、前記構築物を含む細胞、及び疾患の治療において前記細胞を利用する方法 Active JP5745419B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0820397.8 2008-11-07
GBGB0820397.8A GB0820397D0 (en) 2008-11-07 2008-11-07 Cells, nucleic acid constructs, cells comprising said constructs and methods utilizing said cells in the treatment of diseases
PCT/EP2009/064788 WO2010052313A1 (en) 2008-11-07 2009-11-06 Cells, nucleic acid constructs, cells comprising said constructs and methods utilizing said cells in the treatment of diseases

Publications (3)

Publication Number Publication Date
JP2012507997A JP2012507997A (ja) 2012-04-05
JP2012507997A5 true JP2012507997A5 (cg-RX-API-DMAC7.html) 2012-12-20
JP5745419B2 JP5745419B2 (ja) 2015-07-08

Family

ID=40139550

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011535119A Active JP5745419B2 (ja) 2008-11-07 2009-11-06 細胞、核酸構築物、前記構築物を含む細胞、及び疾患の治療において前記細胞を利用する方法

Country Status (9)

Country Link
US (1) US9012220B2 (cg-RX-API-DMAC7.html)
EP (1) EP2361261B1 (cg-RX-API-DMAC7.html)
JP (1) JP5745419B2 (cg-RX-API-DMAC7.html)
KR (1) KR101666692B1 (cg-RX-API-DMAC7.html)
AU (1) AU2009312700B2 (cg-RX-API-DMAC7.html)
CA (1) CA2742698C (cg-RX-API-DMAC7.html)
ES (1) ES2479540T3 (cg-RX-API-DMAC7.html)
GB (1) GB0820397D0 (cg-RX-API-DMAC7.html)
WO (1) WO2010052313A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0918615D0 (en) * 2009-10-23 2009-12-09 Cellerix Sa Cell populations having immunoregulatory activity, methods for the preparation and uses thereof
KR20140016933A (ko) * 2011-03-11 2014-02-10 타이제닉스, 에스.에이.유. 면역조절 활성을 갖는 세포군, 분리방법 및 용도들
EP3985105A1 (en) * 2020-10-16 2022-04-20 Uniwersytet Gdanski Conditioned regulatory t cell population tregs with enhanced therapeutic potential, method for obtaining of conditioned tregs and the medical use of the tregs population
EP3985106A1 (en) * 2020-10-16 2022-04-20 Uniwersytet Gdanski Conditioned regulatory t cell population with enhanced therapeutic potential, method for obtaining of regulatory t cell population and the medical use of regulatory t cell population

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999029852A1 (en) * 1997-12-05 1999-06-17 Medical College Of Georgia Research Institute, Inc. High-affinity tryptophan transporter
US20030139361A1 (en) 2000-01-21 2003-07-24 Kazuhiro Yuda Drug for gene therapy
EP1501918A4 (en) * 2002-04-12 2006-03-29 Med College Georgia Res Inst ANTIGEN PRESENTING CELL POPULATIONS AND THEIR USE AS REAGENTS TO INCREASE OR REDUCE IMMUNO TOLERANCE
EP1369114A1 (en) 2002-06-07 2003-12-10 Peter Priv. Doz. Dr. Terness Use of tryptophan metabolites as pharmaceutical agents
SI1739166T1 (sl) * 2005-07-01 2011-11-30 Txcell S A PRIDOBIVANJE CELIC Tr1 SPECIFIČNIH ZA ALIMENTARNI ANTIGEN ALI AVTOGEN IZ LEVKOCITNE ALI PBMC POPULACIJE
PT1926813T (pt) 2005-09-23 2016-09-06 Consejo Superior Investigacion Populações de células que têm atividade imunorreguladora, método para isolamento e usos
US20080293070A1 (en) 2005-12-21 2008-11-27 Rafick-Pierre Sekaly Markers for Memory T Cells and Uses Thereof
EP1981534A4 (en) * 2006-01-07 2012-04-04 Med College Georgia Res Inst INDOLAMINE-2,3-DIOXYGENASE WAYS IN GENERATING REGULATORY T CELLS
US20080155704A1 (en) * 2006-12-22 2008-06-26 King's College London Methods and Compositions for Determining in vivo Activity of BiP
WO2008100562A2 (en) 2007-02-14 2008-08-21 Medical College Of Georgia Research Institute, Inc. Indoleamine 2,3-dioxygenase, pd-1/pd-l pathways, and ctla4 pathways in the activation of regulatory t cells
US8685728B2 (en) * 2008-01-31 2014-04-01 Rutgers The State University Of New Jersey Kit containing stem cells and cytokines for use in attenuating immune responses
US9228172B2 (en) * 2008-06-19 2016-01-05 The Trustees Of The University Of Pennsylvania Inducible regulatory T-cell generation for hematopoietic transplants

Similar Documents

Publication Publication Date Title
NZ630009A (en) Angiogenesis using placental stem cells
WO2011049414A3 (ko) 지방조직 유래 성체 줄기세포 이동을 유도하는 방법
WO2012065027A3 (en) Compositions, kits and methods for treatment of cardiovascular, immunological, and inflammatory diseases
JP2014527821A5 (cg-RX-API-DMAC7.html)
NZ612801A (en) Ultrasonic cavitation derived stromal or mesenchymal vascular extracts and cells derived therefrom obtained from adipose tissue and use thereof
MX2013002381A (es) Celulas precursoras cd27 1 derivadas de medula osea para reparacion cardiaca.
WO2013013025A3 (en) Anti-cxcr4 antibodies and methods of use
AU2009240884A8 (en) Agent for recruitment of bone-marrow-derived pluripotent stem cell into peripheral circulation
MY170013A (en) Methods and compositions for enhancing stem cell mobilization
ES2685319T3 (es) Generación de células marcapasos basada en factor de transcripción y métodos de uso de las mismas
WO2014093051A3 (en) Cardiac stem cells and methods of identifying and using the same
MX362098B (es) El uso de células derivadas de tejido del cordón umbilical y kits que contienen las mismas para el tratamiento de enfermedad vascular periférica.
MX2013000986A (es) Sirna dirigido al vegfa y metodos de tratamiento in vivo.
JP2017536826A5 (cg-RX-API-DMAC7.html)
WO2013056049A3 (en) Tubular prostheses
JP2012507997A5 (cg-RX-API-DMAC7.html)
Kobielak et al. Skin and skin appendage regeneration
EP2623106A4 (en) Composition for regenerating follicle which contains cd36-expressing connective tissue sheath cells
ES2479540T1 (es) Células, construcciones de ácido nucleico, células que comprenden dichas construcciones y métodos que utilizan dichas células en el tratamiento de enfermedades
MX2021003798A (es) Terapia con celulas de placenta humana y celulas hematopoyeticas.
WO2012050829A3 (en) Uses of il-12 and the il-12 receptor positive cell in tissue repair and regeneration
Cruz et al. C34 NEW BASIC SCIENCE IN ASTHMA: ALLERGIC INFLAMMATION I: Cd11b And Sca-1 Positive Cells Exert The Main Beneficial Effects Of Bone Marrow-Derived Mononuclear Cell Therapy In A Murine Model Of Severe Asthma
Hsieh et al. C55 ADVANCES IN PULMONARY VASCULAR CELL BIOLOGY: Cathepsin S Degrades The Tropoelastin In Obliterative Pulmonary Vascular Lesions
林俊 Clinical study of sirolimus-associated interstitial pneumonitis in kidney transplant recipients
张燕 Hematopoietic reconstitution on the prognosis of hematological malignancies after allogenceic hematopoietic stem cell transplantation